BioCatalyst

TRK-950, Ramucirumab, Paclitaxel — catalyst calendar

1 verified catalyst event(s) referencing TRK-950, Ramucirumab, Paclitaxel, each linked to its official source. Verified as of 2026-06-22.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-06-30
in 8d
ESTIMATED
 READOUT
A Study of TRK-950 When Used in Combination With Ramucirumab and Paclitaxel in P
Phase 2 · Gastric Adenocarcinoma, Gastric Cancer
 Toray Industries, Inc TRK-950, Ramucirumab, Paclitaxel ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.